Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.595.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.595.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.595.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.76.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.76.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.76.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.76.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.38.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.38.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.38.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.38.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.38.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.38.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.38.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.38.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.50NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
B.1.494ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.494ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.494ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.494NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.167ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.167ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.167ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.167NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.267ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.267ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.267ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.267NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.165ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.165ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.165ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.165NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
B.1.554ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.554ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.554ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.554NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.243.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.243.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.243.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.243.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.2.5.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.2.5.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.5.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used